APA-viite

Zalutsky, M. R., Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., . . . Bigner, D. D. (2007). Clinical Experience with α-Particle–Emitting (211)At: Treatment of Recurrent Brain Tumor Patients with (211)At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6.

Chicago-tyylinen lähdeviittaus

Zalutsky, Michael R., David A. Reardon, Gamal Akabani, R. Edward Coleman, Allan H. Friedman, Henry S. Friedman, Roger E. McLendon, Terence Z. Wong, ja Darell D. Bigner. Clinical Experience With α-Particle–Emitting (211)At: Treatment of Recurrent Brain Tumor Patients With (211)At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6. 2007.

MLA-viite

Zalutsky, Michael R., et al. Clinical Experience With α-Particle–Emitting (211)At: Treatment of Recurrent Brain Tumor Patients With (211)At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6. 2007.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.